Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL J PAYETTE

Allopathic & Osteopathic Physicians Dermatology

NPI
1952575573
CMS profile
315556
Location
CROMWELL, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$631,199.35

798 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 16 of 16; records 751–798 of 798 matching records. This page contains 48 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL J PAYETTE

NPI 1952575573 · CMS profile ID 315556

Allopathic & Osteopathic Physicians / Dermatology

CROMWELL, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 16 of 16; records 751–798 of 798 matching records. This page contains 48 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1952575573?year=2023&recipient=provider&page=16#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL J PAYETTE, NPI 1952575573, CMS profile ID 315556. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 16 of 16; records 751–798 of 798 matching records. This page contains 48 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1952575573?year=2023&recipient=provider&page=16#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MICHAEL J PAYETTE, NPI 1952575573, CMS profile ID 315556. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 16 of 16; records 751–798 of 798 matching records. This page contains 48 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1952575573?year=2023&recipient=provider&page=16#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MICHAEL J PAYETTE, NPI 1952575573, CMS profile ID 315556, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 16 of 16; records 751–798 of 798 matching records. This page contains 48 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1952575573?year=2023&recipient=provider&page=16#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

798 matching records · $631,199.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 798 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 751–798 of 798.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novartis Pharmaceuticals Corporation $15.4101/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992926161 CMS
Arcutis Biotherapeutics, Inc. $23.4101/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044802659 CMS
UCB, Inc. $6.7401/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021385669 CMS
ABBVIE INC. $19.0601/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998109927 CMS
E.R. Squibb & Sons, L.L.C. $8.3401/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970959 CMS
Janssen Biotech, Inc. $26.6101/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988330211 CMS
E.R. Squibb & Sons, L.L.C. $120.2001/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970929 CMS
Sun Pharmaceutical Industries Inc. $13.4001/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053927505 CMS
Dermavant Sciences, Inc. $23.7601/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991236143 CMS
Janssen Biotech, Inc. $4.9401/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988330147 CMS
Janssen Biotech, Inc. $34.9801/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988330199 CMS
Incyte Corporation $3,300.0001/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044187873 CMS
Dermavant Sciences, Inc. $180.0401/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991236139 CMS
Janssen Biotech, Inc. $22.0901/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988330189 CMS
LEO Pharma Inc. $7.9301/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053513687 CMS
PFIZER INC. $11.3801/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050517891 CMS
Regeneron Healthcare Solutions, Inc. $28.9501/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999359797 CMS
Arcutis Biotherapeutics, Inc. $750.0001/19/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044802439 CMS
E.R. Squibb & Sons, L.L.C. $30.0601/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970933 CMS
Incyte Corporation $23.7301/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044187823 CMS
LEO Pharma Inc. $12.2801/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053513681 CMS
PFIZER INC. $6.2101/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049558897 CMS
Lilly USA, LLC $25.9001/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1031844491 CMS
Janssen Biotech, Inc. $30.2801/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988330179 CMS
Arcutis Biotherapeutics, Inc. $66.1501/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044802741 CMS
E.R. Squibb & Sons, L.L.C. $42.7501/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970991 CMS
Arcutis Biotherapeutics, Inc. $105.0001/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044802761 CMS
Novartis Pharmaceuticals Corporation $113.3901/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 992926151 CMS
ABBVIE INC. $100.0501/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998109925 CMS
Janssen Scientific Affairs, LLC $63.6301/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988543663 CMS
E.R. Squibb & Sons, L.L.C. $29.0201/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970921 CMS
E.R. Squibb & Sons, L.L.C. $115.6601/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970945 CMS
Regeneron Healthcare Solutions, Inc. $21.7901/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999359793 CMS
Dermavant Sciences, Inc. $102.9901/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991236135 CMS
Regeneron Healthcare Solutions, Inc. $4,215.0001/10/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999359787 CMS
Regeneron Healthcare Solutions, Inc. $38.2301/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999359781 CMS
Almirall LLC $20.7601/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038196423 CMS
Regeneron Healthcare Solutions, Inc. $36.4101/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999359775 CMS
UCB, Inc. $8.9301/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1021385705 CMS
ABBVIE INC. $21.7401/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998109923 CMS
E.R. Squibb & Sons, L.L.C. $4.5501/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970925 CMS
Incyte Corporation $90.2201/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044187847 CMS
Incyte Corporation $1,171.5701/05/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044187859 CMS
ABBVIE INC. $11.1701/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998109921 CMS
Dermavant Sciences, Inc. $25.3401/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991236131 CMS
E.R. Squibb & Sons, L.L.C. $5,015.0001/03/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015970913 CMS
Incyte Corporation $23.1601/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044187811 CMS
LEO Pharma Inc. $13.5301/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053513675 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $142,249.36 284
PY2020 $91,236.69 221
PY2021 $163,722.86 341
PY2022 $460,029.84 666
PY2023 $631,199.35 798
PY2024 $848,239.56 1,033
PY2025 $851,481.87 954

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $12,319.00 12
PY2022 Principal investigator $79,947.40 10
PY2021 Principal investigator $35,727.25 6
PY2020 Principal investigator $89,948.98 13

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Incyte Corporation $304.70 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515078
Principal investigator 1 Incyte Corporation $2,022.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515081
Principal investigator 1 Incyte Corporation $2,648.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515085
Principal investigator 1 Incyte Corporation $90.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515089
Principal investigator 1 Incyte Corporation $63.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515093
Principal investigator 1 Incyte Corporation $63.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515097
Principal investigator 1 Incyte Corporation $63.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515101
Principal investigator 1 Incyte Corporation $1,932.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515105
Principal investigator 1 Incyte Corporation $243.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515109
Principal investigator 1 Incyte Corporation $2,148.00 12/19/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515122
Principal investigator 1 Incyte Corporation $104.00 11/21/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515113
Principal investigator 1 Incyte Corporation $2,638.30 11/21/2025 Non-covered Recipient Entity
CENTRAL CONNECTICUT DERMATOLOGY
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in participants with hidradenitis suppurativa. No dispute reported 06/30/2026 1240515118